Wolverine Trading’s AMAG Pharmaceuticals AMAG Stock Holding History

Wolverine Trading’s Portfolio AMAG Stock Details AMAG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-26,900	Closed	-$327K	–	5624
2019 Q4	$327K	Buy	26,900 +14,100	+110%	+$154K	﹤0.01%	3485
2019 Q3	$155K	Sell	12,800 -13,800	-52%	-$145K	﹤0.01%	3703
2019 Q2	$266K	Buy	26,600 +10,800	+68%	+$117K	﹤0.01%	3396
2019 Q1	$204K	Buy	+15,800	New	+$235K	﹤0.01%	3803
2018 Q4	–	Sell	-16,300	Closed	-$326K	–	5726
2018 Q3	$326K	Buy	+16,300	New	+$371K	﹤0.01%	3649
2017 Q3	–	Sell	-52,100	Closed	-$951K	–	5322
2017 Q2	$951K	Buy	52,100 +10,100	+24%	+$200K	﹤0.01%	1789
2017 Q1	$964K	Buy	+42,000	New	+$1.01M	0.01%	1751
2016 Q4	–	Sell	-41,800	Closed	-$1M	–	5448
2016 Q3	$1M	Buy	+41,800	New	+$1.04M	﹤0.01%	1851

Wolverine Trading's AMAG Position: Q2 2017 in Review

Wolverine Trading sold out of AMAG Pharmaceuticals (AMAG) in Q2 2017, closing a stake of 19,069 shares — an estimated $378K sold.

Wolverine Trading first reported a position in AMAG in Q1 2017 and held it in 1 quarter. The position peaked at $438K in Q1 2017. 174 funds tracked by Wall St. Rank hold AMAG as of Q2 2017.

Wolverine Trading reported no remaining AMAG Pharmaceuticals position as of Q2 2017 after selling out during the quarter.
Wolverine Trading sold 19,069 AMAG Pharmaceuticals shares in Q2 2017, an estimated $378K.
Wolverine Trading first reported a position in AMAG Pharmaceuticals in Q1 2017 and held it in 1 quarter.
Wolverine Trading's AMAG Pharmaceuticals position peaked at $438K in Q1 2017.
174 funds tracked by Wall St. Rank held AMAG Pharmaceuticals as of Q2 2017.

Based on Wolverine Trading's 13F filing for Q2 2017, filed 14 Aug 2017.